Not Yet Recruiting
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
NCT06998095
- Conditions
- Asthma, Bronchial Diseases, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP), +8 more
- Locations
-
Not specified